Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (331-340 of 528) with videos related to

Pageof 53
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissueRavi J Menezes, Richard T Cheney, Aliya Husain, et al.
American Journal of Clinical Oncology|January 6, 2022
Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC)Jason Liu, Emily Bratton, Xinyan Yu, et al.
Biophysical Reviews|January 21, 2022
Protein conformational dynamics and phenotypic switchingPrakash Kulkarni, Srisairam Achuthan, Supriyo Bhattacharya, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2018
Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)James J Urbanic, Xiaofei Wang, Jeffrey A Bogart, et al.
Clinical Lung Cancer|September 15, 2023
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung CancerMaryam Ebadi, Colton Ladbury, Jason Liu, et al.
Cancers|January 11, 2025
The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective StudyRamya Muddasani, Helena T Wu, Shwe Win, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 14, 2009
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcriptionRajani Kanteti, Vidya Nallasura, Sivakumar Loganathan, et al.
Molecular Cancer|December 30, 2025
Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMari Iida, Toni M Brand, Megan M Starr, et al.
Gynecologic Oncology|April 22, 2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Cancer Research|September 10, 2009
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transitionJianbo Yang, Matthew A Price, Gui Yuan Li, et al.
Pageof 53

Showing results (331-340 of 528) with videos related to

Sort By:
Pageof 53
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissueRavi J Menezes, Richard T Cheney, Aliya Husain, et al.
American Journal of Clinical Oncology|January 6, 2022
Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC)Jason Liu, Emily Bratton, Xinyan Yu, et al.
Biophysical Reviews|January 21, 2022
Protein conformational dynamics and phenotypic switchingPrakash Kulkarni, Srisairam Achuthan, Supriyo Bhattacharya, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2018
Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)James J Urbanic, Xiaofei Wang, Jeffrey A Bogart, et al.
Clinical Lung Cancer|September 15, 2023
Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent Non-Small-Cell Lung CancerMaryam Ebadi, Colton Ladbury, Jason Liu, et al.
Cancers|January 11, 2025
The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective StudyRamya Muddasani, Helena T Wu, Shwe Win, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 14, 2009
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcriptionRajani Kanteti, Vidya Nallasura, Sivakumar Loganathan, et al.
Molecular Cancer|December 30, 2025
Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMari Iida, Toni M Brand, Megan M Starr, et al.
Gynecologic Oncology|April 22, 2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II ConsortiaHalla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Cancer Research|September 10, 2009
Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transitionJianbo Yang, Matthew A Price, Gui Yuan Li, et al.
Pageof 53